Deerfield, Illinois
February 6, 2006
High lysine technology will provide higher
level of essential amino acid than conventional feed corn
Renessen LLC announced
today that the U.S. Department of Agriculture has
deregulated Renessen's high lysine corn containing the LY038
trait, clearing the way for Renessen to commercialize the
new technology for use in the livestock industry. To be sold
under the name Mavera(TM) High Value Corn with Lysine, LY038
is the world's first crop-based quality trait produced
through biotechnology for the animal feed industry. It also
represents the first biotechnology trait offering from
Renessen.
The technology provides higher
levels of lysine than a conventional corn plant produces.
Lysine, an amino acid, is a critical building block for proteins
and muscle and thus essential for the diets of animals. When
included as part of an animal's diet, grain produced that
contains the trait will enhance lysine levels in animal feed,
reducing the need for synthetic lysine supplements. It is
expected to reduce cost and improve efficiency for animal
producers.
"We are very excited by this
technology's ability to simplify our livestock customers' animal
feed rations and improve operational efficiency through cost
savings," said Michael Stern, Ph.D., chief executive officer for
Renessen.
The high-lysine trait will be
marketed under Renessen's Mavera(TM) program. The specially
developed corn will contain higher levels of corn oil than
commodity hybrids, in addition to possessing the lysine trait,
and it will initially be sold through the Asgrow® brand of seed.
"Mavera(TM) High Value Corn with Lysine offers the increased oil
and metabolizable energy content of Mavera(TM) High Value Corn,
with the added benefits of providing an enhanced level of the
essential amino acid lysine," added Stern. "This will create
additional planting options for corn growers, allowing them to
earn a premium while participating in a value-added supply
chain."
Mavera(TM) High Value Corn with
Lysine will be evaluated under an experimental field program in
2006 and produced on limited acreage in 2007. The new product
will initially be grown in states with access to major river
ways such as Illinois and Indiana so that export markets can be
reached economically.
Renessen is currently seeking
the necessary regulatory clearances for LY038 in all key import
markets, and until those approvals are obtained, grain
containing LY038 will only be marketed to specific end users in
the United States. Regardless of its destination, LY038 grain
will always be produced under an identity preservation system,
which will control the flow of the grain from the farm to the
end-user. Mavera(TM) High Value Corn with Lysine will initially
be combined with the YieldGard® Corn Borer trait in the U.S.
market, to be followed later with other Monsanto agronomic
traits, such as the YieldGard® Corn Rootworm and Roundup Ready®
Corn II traits.
Renessen is a joint venture
between Cargill Incorporated
and Monsanto Company,
bringing together Monsanto's expertise in biotechnology and
plant breeding with Cargill's capabilities in animal nutrition,
grain processing and logistics. Since its establishment in 1999,
Renessen has been focused on developing valued-added traits to
the feed industry.
Renessen LLC is an innovative
biotechnology company dedicated to developing quality traits for
the feed and processing industry. It is a joint venture between
Cargill Inc. and Monsanto Company.
Cargill Incorporated is an
international provider of food, agricultural and risk management
products and services. With 124,000 employees in 59 countries,
the company is committed to using its knowledge and experience
to collaborate with customers to help them succeed.
Monsanto Company is a
leading global provider of technology-based solutions and
agricultural products that improve farm productivity and food
quality. |